Visitors Now: | |
Total Visits: | |
Total Stories: |
Story Views | |
Now: | |
Last Hour: | |
Last 24 Hours: | |
Total: |
Should a drug that produces sexual dysfunction for the majority of users and which doubles the risk of a suicide attempt be labeled an antidepressant? No, argues a recent Scientifica article, “Relabeling the Medications We Call Antidepressants.” The article’s authors, David Antonuccio, psychologist at the Department of Psychiatry and Behavioral Sciences, University of Nevada School of Medicine, and David Healy, psychiatrist at the Department of Psychological Medicine, Bangor University in the UK, point out that “to call these medications antidepressants may make sense from a marketing standpoint but may be misleading from a scientific perspective.” They conclude that “it may make just as much sense to call these medications antiaphrodisiacs as antidepressants because the negative effects on libido and sexual functioning are so common.”
If a greater percentage of antidepressant users suffer from sexual dysfunction than are relieved of depression, in a scientific sense, it is not silly to label the medication in terms of the condition that it affects most? And while Prozac, Paxil and Zoloft are antidepressants for some people, for other people they are suicidality inducers, agitation enhancers and mania stimulators.
The complete article: http://www.alternet.org/health/156232/ta…_misnamed/
Read more at Ye Olde False Flag